Cardiovascular Care
June 7, 2010
Electronic Prescribing Increases Generic and Formulary Drug Use
Electronic prescribing resulted in greater generic and formulary drug use, according to Crystal Chang, PharmD, and colleagues at Blue Shield of California, San Francisco. It also led to an average cost savings of 17.3% for both the member and the payer.
More »
April 16, 2010
Evidence-Based Perspective on Metabolic Syndrome and Use of Antipsychotics
Schizophrenia, a devastating mental illness that affects nearly 2.2 million Americans, is associated with high rates of morbidity and mortality.1 Persons with schizophrenia have a 20% shorter life expectancy than the general population.1,2 Furthermore, among persons with schizophrenia, there is an increased prevalence of metabolic syndrome characterized by a constellation of risk factors, including insulin resistance, abdominal obesity, dyslipidemia, hyperglycemia, and hypertension,3 More »
April 15, 2010
Reducing Cost-Related Medication Nonadherence in Patients With Diabetes
In the United States, it has been estimated that 7.8% of the total population has diabetes. In 2007, the direct medical expenditures for diabetes were about $116 billion and the total direct and indirect costs were $174 billion, according to the CDC.1 More »
March 26, 2010
Workers Fear Stigma of Mental Health Treatment
A national survey done by the American Psychiatric Association (APA) showed that workers are hesitant to seek treatment for mental health issues. Reasons cited included concerns about confidentiality or fears of loss of status in the workplace. More »
March 26, 2010
Hyperparathyroidism Resulting From Lithium Treatment Remains Underrecognized
Until recently, I never paid much attention to the possibility that abnormalities of the parathyroid glands could be relevant to patients in my practice. But I decided to learn more about this issue when one of my patients with bipolar disorder who had been treated with lithium told me that she had been given a diagnosis of a parathyroid adenoma after her primary care physician noted hypercalcemia on routine testing. More »
Showing 1 - 5 of 46 results.
Page of 10
First Previous Last
Selected Articles

Predicting the Risk of Type 2 Diabetes: When Does the Clock Start Ticking?

American medicine is undergoing the greatest financial scrutiny in its history. The hue and cry for reform stems primarily from the soaring costs of health care. However, placing the blame for these costs solely on increased utilization of technology, cutting-edge pharmaceuticals, cost-shifting hospitals, and physicians misses a bigger mark.

 

Diabetes and Cardiovascular Disease: Does Lowering Hemoglobin A1c Help or Harm?

Conflicting data about the safety and effectiveness of intensive glycemic control have caused confusion over the best approach to cardiovascular risk reduction in patients with diabetes. A recent meta-analysis has helped reconcile these seemingly contradictory data. The optimal mechanism, speed, and extent of glycated hemoglobin reduction are different for differing populations. For patients with recently diagnosed diabetes, aggressive treatment will lower cardiovascular risk. In patients who have diabetes of more than 15 years’ duration and are older and have other comorbidities, less aggressive treatment is indicated. For all patients, treatment of the dyslipidemia and hypertension that are associated with diabetes further reduces cardiovascular risk.

 

Coronary calcium scoring can be trusted to guide cardiac test selection

Coronary artery calcium scanning predicts the risk of myocardial infarction and sudden death accurately enough to guide the selection of diagnostic tests for symptomatic patients, according to a multicenter prospective study. 

 

Falling Through the Cracks: Middle-Aged Stroke Survivors Not Receiving Care

Recurrent stroke is an important health concern not only from a patient perspective but also from clinical and public health standpoints. Many studies have shown that the risk of a second cerebral infarction is greatest immediately following the primary event. Consequently, clinical management of stroke survivors is focused on preventive therapy to minimize risk.Recurrent stroke is an important health concern not only from a patient perspective but also from clinical and public health standpoints. Many studies have shown that the risk of a second cerebral infarction is greatest immediately following the primary event. Consequently, clinical management of stroke survivors is focused on preventive therapy to minimize risk. 
Mashup Tool
Preparing for a Consumer-Driven Genomic Age
www.nejm.org - 9/3/10
related to stroke or cardiovascular events with tiotropium and the potential ... that health care providers payers and patients may all define clinical ...
Preventing Chronic Disease: September 2010: 10_0038
www.cdc.gov - 9/1/10
In health care various stakeholders have revealed their willingness to pay for performance. These include payers such as insurance companies or government agencies like the Centers for Medicare and Medicaid ...
Preventing Chronic Disease: September 2010: 10_0028
www.cdc.gov - 9/1/10
accrue to patients employers providers or payers.” A social case would ...
Prevalence and Predictors of Off-Label Use of Cardiac Resynchronization Therapy in Patients Enrolled in the National Cardiovascu
content.onlinejacc.org - 8/31/10
Patients Enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry ... sex were associated with decreased odds. Physician training and insurance payer were weakly associated with the likelihood of off-label use. ...
Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascu
pubmed.com - 8/31/10
From the National Cardiovascular Data Registry's Implantable Cardiac-Defibrillator Registry we ... sex were associated with decreased odds. Physician training and insurance payer were weakly associated with the likelihood of off-label use. ...

Result Pages: 1 2 3 4 5 6 Previous